SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes.

Kaufman, Harvey W; Letovsky, Stanley; Meyer, William A; Gillim, Laura; Assimon, Magdalene M; Kabelac, Carly A; Kroner, John W; Reynolds, Shannon L; Eisenberg, Marcia

Kaufman, Harvey W; Letovsky, Stanley; Meyer, William A; Gillim, Laura; Assimon, Magdalene M; Kabelac, Carly A; Kroner, John W; Reynolds, Shannon L; Eisenberg, Marcia.

Afiliação

Kaufman HW; Quest Diagnostics®, Secaucus, NJ, United States.
Letovsky S; Labcorp®, Burlington, NC, United States.
Meyer WA; Quest Diagnostics®, Secaucus, NJ, United States.
Gillim L; Labcorp®, Burlington, NC, United States.
Assimon MM; Aetion, Inc.®, New York, NY, United States.
Kabelac CA; Aetion, Inc.®, New York, NY, United States.
Kroner JW; Aetion, Inc.®, New York, NY, United States.
Reynolds SL; Aetion, Inc.®, New York, NY, United States.
Eisenberg M; Labcorp®, Burlington, NC, United States.

Front Public Health ; 11: 1193246, 2023.

Article em En | MEDLINE | ID: mdl-37559735

Assuntos

COVID-19; Humanos; Estados Unidos/epidemiologia; COVID-19/diagnóstico; SARS-CoV-2; Teste para COVID-19; Estudos Retrospectivos; Glicoproteína da Espícula de Coronavírus

Palavras-chave

COVID-19; SARS-CoV-2; SARS-CoV-2 spike antibody; immune protection; immunocompromised conditions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google